FDA Inspection
Xttrium Laboratories, Inc.Xttrium Laboratories, Inc. – FDA Inspection, Jun 18, 2025
Record Details
This FDA Inspection record concerns Xttrium Laboratories, Inc., with an inspection on June 18, 2025, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · ac02e451-de34-435b-bceb-4bf5ef75cc27
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1273417
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Xttrium Laboratories, Inc.
15| Date | Classification | Office | Project area |
|---|---|---|---|
| June 16, 2026 | Not classified | Chicago District Office | |
| March 8, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 6, 2024 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| March 15, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 11, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Xttrium Laboratories, Inc.
- FDA Inspection 1324176 - 2026-06-16
- FDA Inspection 1234354 - 2024-03-08
- FDA Inspection 1230448 - 2024-02-06
- FDA Inspection 1046665 - 2018-03-15
- FDA Inspection 977965 - 2016-07-11
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.